Big Pharma, CDC, EPA & FDA

An FDA committee is meeting next week to review the first COVID vaccine. We must demand that full transparency is given to the American public. Action Alert!
Pfizer has applied for emergency use authorization (EUA) for its COVID-19 vaccine, and an FDA advisory committee will meet in an open session on December 10 to review Pfizer’s data; Moderna recently announced that it, too, has filed for an EUA. We’re being told by the manufacturers that both of these vaccines have above 90% efficacy and serious adverse events are low. That’s all well and good, but we cannot rely on the word of vaccine makers that their products are safe. We need the data, and so far, we are not even close to getting it. This is completely unacceptable. Please let us know what you think of this article in our comment section. Thank you.

There is a possible major breakthrough in the battle against COVID-19. Researchers in Pittsburgh have developed a drug that completely neutralizes the coronavirus. The potential drug is called AB-8, a small piece of the anti-COVID antibodies that have been used to treat COVID patients by blocking or neutralizing the coronavirus. But this very small molecule appears to have major advantages over other drugs, and perhaps even vaccines.

On August 26, Children’s Health Defense (CHD) wrote a letter to Dr. Jerry Menikoff, Director of the Department of Health and Human Services’ Office of Human Research Protection (OHRP), asking for an investigation into serious safety concerns with the COVID-19 vaccine being developed by Moderna. Moderna’s version of the vaccine, championed by Dr. Anthony Fauci and funded with $500 million in taxpayer dollars through Dr. Fauci’s National Institute of Allergy and Infectious Diseases, contains polyethylene glycol (PEG), a molecule to which approximately 72% of the American population have antibodies and 8% have highly elevated levels of antibodies. People who have pre-existing PEG antibodies could experience life-threatening anaphylaxis if injected with PEG-containing substances such as the Moderna COVID vaccine. Additionally, antibodies to PEG can both decrease the effectiveness of the vaccine and increase the risk of side effects.